CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
FTC Questions Apple News Over Alleged Bias Against Conservative Media 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed 
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase 
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth 
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App 
ALLEN, Texas, Nov. 08, 2017 -- Atrion Corporation (Nasdaq:ATRI) today announced that its Board of Directors declared a quarterly cash dividend of $1.20 per share on the Company’s outstanding Common Stock. This dividend will be payable on December 15, 2017 to stockholders of record at the close of business on December 1, 2017.
Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.
Contact:
Jeffery Strickland
Vice President and Chief Financial Officer
(972) 390-9800
